Bonnie L. Bassler - Apr 7, 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**Bonnie L. Bassler
Stock symbol
REGN
Transactions as of
Apr 7, 2022
Transactions value $
-$426,622
Form type
4
Date filed
4/11/2022, 04:38 PM
Previous filing
Apr 1, 2022
Next filing
Jun 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $472K +1.24K +114.6% $380.95 2.32K Apr 7, 2022 Direct F1
transaction REGN Common Stock Sale -$899K -1.24K -53.4% $725.00 1.08K Apr 7, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -1.24K -20% $0.00 4.96K Apr 7, 2022 Common Stock 1.24K $380.95 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.